Showing 1 - 10 of 30,659
We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …
Persistent link: https://www.econbiz.de/10009571756
contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health … ; Innovation ; Pharmaceuticals ; Health care expenditure ; Cointegration …
Persistent link: https://www.econbiz.de/10003900852
contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health … ; Innovation ; Pharmaceuticals ; Health care expenditure ; Cointegration …
Persistent link: https://www.econbiz.de/10003909500
I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-adjusted mortality rates of residents of Germany, using longitudinal, annual, state-level data during the period 2000-2007. The estimates …-adjusted cancer mortality rates of residents of France, using longitudinal, annual, cancer-site-level data during the period 2002 …
Persistent link: https://www.econbiz.de/10013069689
innovation can be systematically distorted. This paper builds a simple model of endogenous technology, which generalizes existing … comparative static results and characterizes potential distortions in the direction of innovation. I show that empirical findings …
Persistent link: https://www.econbiz.de/10014226119
We study the effect of the COVID-19 pandemic on chronic disease drug adherence. Focusing on asthma, we use a database that tracks the vast majority of prescription drug claims in the U.S. from 2018 to 2020. Using a difference-in-differences empirical specification, we compare monthly drug...
Persistent link: https://www.econbiz.de/10014226165
It has been known for centuries that the rich and famous have longer lives than the poor and ordinary. Causality, however, remains trenchantly debated. The ideal experiment would be one in which status and money could somehow be dropped upon a sub-sample of individuals while those in a control...
Persistent link: https://www.econbiz.de/10013317236
We fit the logistic function, the reduced form of epidemic behaviour, to the data for deaths from Covid-19, for a wide variety of countries, with a view to estimating a causal model of the covid virus' progression. We then set out a structural model of the Covid virus behaviour based on...
Persistent link: https://www.econbiz.de/10012229838
several health outcomes and find that, in general, increased openness is associated with lower rates of infant mortality and …
Persistent link: https://www.econbiz.de/10014123069
between 1990 and 2014 from the World Health Organization and country-level mobile phone subscription rates from the World Bank …
Persistent link: https://www.econbiz.de/10014132617